N-acetylcysteine and taurine prevent hyperglycemia-induced insulin resistance in vivo: possible role of oxidative stress

被引:178
作者
Haber, CA
Lam, TKT
Yu, ZW
Gupta, N
Goh, T
Bogdanovic, E
Giacca, A
Fantus, IG
机构
[1] Mt Sinai Hosp, Dept Med, Toronto, ON M5G 1X5, Canada
[2] Univ Toronto, Dept Physiol, Toronto, ON M5G 1X5, Canada
[3] Univ Toronto, Banting & Best Diabet Ctr, Toronto, ON M5G 1X5, Canada
来源
AMERICAN JOURNAL OF PHYSIOLOGY-ENDOCRINOLOGY AND METABOLISM | 2003年 / 285卷 / 04期
关键词
euglycemic clamp; insulin resistance; protein carbonyls; protein kinase C; antioxidants;
D O I
10.1152/ajpendo.00355.2002
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Exposure to high concentrations of glucose and insulin results in insulin resistance of metabolic target tissues, a characteristic feature of type 2 diabetes. High glucose has also been associated with oxidative stress, and increased levels of reactive oxygen species have been proposed to cause insulin resistance. To determine whether oxidative stress contributes to insulin resistance induced by hyperglycemia in vivo, nondiabetic rats were infused with glucose for 6 h to maintain a circulating glucose concentration of 15 mM with and without coinfusion of the antioxidant N-acetylcysteine (NAC), followed by a 2-h hyperinsulinemic-euglycemic clamp. High glucose (HG) induced a significant decrease in insulin-stimulated glucose uptake [tracer-determined disappearance rate (R-d), control 41.2 +/- 1.7 vs. HG 32.4 +/- 1.9 mg . kg(-1) . min(-1), P < 0.05], which was prevented by NAC (HG + NAC 45.9 +/- 3.5 mg . kg(-1) . min(-1)). Similar results were obtained with the antioxidant taurine. Neither NAC nor taurine alone altered Rd. HG caused a significant (5-fold) increase in soleus muscle protein carbonyl content, a marker of oxidative stress that was blocked by NAC, as well as elevated levels of malondialdehyde and 4-hydroxynonenal, markers of lipid peroxidation, which were reduced by taurine. In contrast to findings after long-term hyperglycemia, there was no membrane translocation of novel isoforms of protein kinase C in skeletal muscle after 6 h. These data support the concept that oxidative stress contributes to the pathogenesis of hyperglycemia-induced insulin resistance.
引用
收藏
页码:E744 / E753
页数:10
相关论文
共 87 条
  • [11] INSULIN RESISTANCE IN RATS WITH NON-INSULIN-DEPENDENT DIABETES INDUCED BY NEONATAL (5 DAYS) STREPTOZOTOCIN - EVIDENCE FOR REVERSAL FOLLOWING PHLORIZIN TREATMENT
    BLONDEL, O
    BAILBE, D
    PORTHA, B
    [J]. METABOLISM-CLINICAL AND EXPERIMENTAL, 1990, 39 (08): : 787 - 793
  • [12] PROTEIN-KINASE-C DIRECTLY PHOSPHORYLATES THE INSULIN-RECEPTOR INVITRO AND REDUCES ITS PROTEIN-TYROSINE KINASE-ACTIVITY
    BOLLAG, GE
    ROTH, RA
    BEAUDOIN, J
    MOCHLYROSEN, D
    KOSHLAND, DE
    [J]. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1986, 83 (16) : 5822 - 5824
  • [13] PHARMACOKINETICS OF N-ACETYLCYSTEINE IN MAN
    BORGSTROM, L
    KAGEDAL, B
    PAULSEN, O
    [J]. EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY, 1986, 31 (02) : 217 - 222
  • [14] BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3
  • [15] Biochemistry and molecular cell biology of diabetic complications
    Brownlee, M
    [J]. NATURE, 2001, 414 (6865) : 813 - 820
  • [16] Effect of α-lipoic acid supplementation on oxidative protein damage in the streptozotocin-diabetic rat
    Çakatay, U
    Telci, A
    Kayali, R
    Sivas, A
    Akçay, T
    [J]. RESEARCH IN EXPERIMENTAL MEDICINE, 2000, 199 (04) : 243 - 251
  • [17] Meal-generated oxidative stress in type 2 diabetic patients
    Ceriello, A
    Lizzio, S
    Bortolotti, N
    Russo, A
    Motz, E
    Tonutti, L
    Crescentini, A
    Taboga, C
    [J]. DIABETES CARE, 1998, 21 (09) : 1529 - 1533
  • [18] Meal-induced oxidative stress and low-density lipoprotein oxidation in diabetes: The possible role of hyperglycemia
    Ceriello, A
    Bortolotti, N
    Motz, E
    Pieri, C
    Marra, M
    Tonutti, L
    Lizzio, S
    Feletto, F
    Catone, B
    Taboga, C
    [J]. METABOLISM-CLINICAL AND EXPERIMENTAL, 1999, 48 (12): : 1503 - 1508
  • [19] Cho C, 1999, DIABETES, V48, pA257
  • [20] Cotgreave I A, 1997, Adv Pharmacol, V38, P205